MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$11,539K
EPS
-$0.48
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Research and development (including 15, 12, 30 and 25 for a related party)
9,018
4,395*
9,126
8,440
General and administrative (including 93, 37, 160 and 188 for a related party)
3,368
4,253*
3,615
3,816
Total operating expenses
12,386
8,647
12,741
12,256
Loss from operations
-12,386
-8,647*
-12,741
-12,256
Change in fair value of tranche liability (including 0, 0, 0 and 331 for a related party)
0
365*
0
0
Change in fair value of derivative liabilities (including 0, 0, 0 and 1,165 for a related party)
0
1,229*
0
0
Interest expense (including 0, 0, 0 and 1,384 for a related party)
0
1,443*
0
0
Loss on extinguishment and on issuance of convertible promissory notes (including 0, 0, 0 and 169 for a related party)
0
-186*
0
0
Other income, net
871
120*
847
906
Total other income, net
871
85*
847
906
Net loss
-11,515
-8,563*
-11,894
-11,350
Unrealized gain on marketable securities, net of tax
-24
-12
6
-
Total other comprehensive gain
-24
-12*
6
-
Comprehensive loss
-11,539
-8,575
-11,888
-
Basic EPS
-0.48
-1.021
-0.64
-0.61
Diluted EPS
-0.48
-1.021
-0.64
-0.61
Basic Average Shares
23,797,306
8,400,457
18,701,708
18,701,286
Diluted Average Shares
23,797,306
8,400,457
18,701,708
18,701,286
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$11,539K
Other income, net
$871K
(-3.86%↓ Y/Y)
Net loss
-$11,515K
(-1.45%↓ Y/Y)
Total other
comprehensive gain
-$24K
Total other income,
net
$871K
(-3.86%↓ Y/Y)
Loss from operations
-$12,386K
(-1.06%↓ Y/Y)
Unrealized gain on
marketable securities, net...
-$24K
Total operating
expenses
$12,386K
(1.06%↑ Y/Y)
Research and development
(including 15, 12, 30 and 25...
$9,018K
(6.85%↑ Y/Y)
General and
administrative (including 93,...
$3,368K
(-11.74%↓ Y/Y)
Buy us a coffee
Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS)